Concepedia

Lori K. Gavrin

LK

Statistics

Publications

9

Citations

611

H-Index

9

Active since

2005

Affiliations

Pfizer (United States)(Current)

Inflammation Research Foundation

Women's Health Research Institute

Lori K. Gavrin is an author at Pfizer (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

2005–2017

9

Publications

9

Approaches to discover non-ATP site kinase inhibitors

Lori K. Gavrin, Eddine Saiah · MedChemComm · 2012 · 177 citations

, , +12

Discovery of Clinical Candidate 1-{[(2 <i>S</i> ,3 <i>S</i> ,4 <i>S</i> )-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design

Katherine L. Lee, Catherine M. Ambler, David R. Anderson et al. · Journal of Medicinal Chemistry · 2017 · 145 citations · Full text

, , +17

Inhibition of Tpl2 kinase and TNFα production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritis

Yonghan Hu, Neal Green, Lori K. Gavrin et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 62 citations · Full text

, , +15

Small Molecules That Target Protein Misfolding

Lori K. Gavrin, R. Aldrin Denny, Eddine Saiah · Journal of Medicinal Chemistry · 2012 · 51 citations · Full text

, , +17

Synthesis of Pyrazolo[1,5-α]pyrimidinone Regioisomers

Lori K. Gavrin, Arthur Lee, Brian A. Provencher et al. · The Journal of Organic Chemistry · 2006 · 50 citations

, , +8

1–5 of 9